Loren Data's SAM Daily™

FBO DAILY ISSUE OF FEBRUARY 28, 2008 FBO #2285
SOURCES SOUGHT

65 -- Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Disposable Protective Apparel-Laboratory Apparel

Notice Date

2/26/2008
 

Notice Type

Sources Sought
 

Contracting Office

Great Plains Regional Contracting Ofc, ATTN: MCAA GP L31 9V, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234-6200
 

ZIP Code

78234-6200
 

Solicitation Number

DADA09-08-T9009
 

Response Due

3/18/2008
 

Archive Date

5/17/2008
 

Point of Contact

kevin.w.hill1, 210-292-3270
 

E-Mail Address

Email your questions to Great Plains Regional Contracting Ofc
(kevin.w.hill1@us.army.mil)
 

Small Business Set-Aside

N/A
 

Description

A. General Information. The Central Region (6, 7 & 8), a military integrated delivery network, comprised of 42 Army, Navy, Air Force Medical Treatment Facilities (MTFs) in the states of Arizona, Arkansas, Colorado, Idaho, Kansas, Louisia na, Missouri, Oklahoma, Nebraska, Nevada, New Mexico, North Dakota, South Dakota, Texas, Utah, and Wyoming, announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Disposable Protective Apparel-Laboratory Apparel. The primary objective of this program is to standardize the quality of care across the region based on a best value determination that represents the clinically preferred product or source(s) at the best possible price. It is also intended that s tandardized products be obtained through the DoD Prime Vendor Program. The major facilities in the region include but are not limited to Brooke Army Medical Center Fort Sam Houston TX; Wilford Hall Medical Center Lackland AFB, TX; Darnall Army Med ical Center, Fort Hood, TX; Reynolds ACH Fort Sill, OK; William Beaumont Army Medical Center Fort Bliss, TX; 10th Medical Group USAF Academy, CO; Evans ACH Fort Carson CO; Fort Leonard Wood ACH, MO; Fort Riley, KS, 99th Medical Group Nellis AFB, NV; and Ba yne-Jones ACH Fort Polk, LA. This standardization action is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia (DSCP), Directorate of Medical Materiel. In order to participate, your company mus t have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendor for the program. This is pursuant to the DAPA clause by which DAPA holders agree to the Standardization process and to allow Prime Vendors to dist ribute their products. This RFRIAQ is a supplement to the Prime Vendor Program and is not a contract. For additional information regarding DSCPs Prime vendor program please access their web site at https://dmmonline.dscp.dla.mil The resulting Regi onal Incentive Agreement (RIA) will be for a base period of two years (24 months) from date of selection with three12-month option periods. Anticipated selection date is May 2008. The evaluation will be based on clinical, technical, and pricing factors. The Technical/Company and Clinical/Performance evaluation factors are considered significantly more important than cost or price. As the technical and clinical evaluation results become more equal, price will become more important. The selection will be determined utilizing Best value/ trade-off criteria. The selection of a single vendor is anticipated. However, if no single vendor can meet the total requirement of the Region, the Government reserves the right to make two or more selections for RIAs. I n this event, selection would be based on a combination of MTF preference and product availability. B. Products & Performance Required. The Central Region (6, 7 & 8) is seeking product line items in the category of Disposable Prote ctive Apparel-Laboratory Apparel, which at a minimum includes the high volume lines below. Within this region, this product line has an estimated annual dollar requirement of $180,985.98. This is included as a reporting metric. This forecast is based on historical prime vendor sales during a recent 12-month period. The top high volume usage lines for this project include: Professional Jacket with knit cuffs  Universal Size; Non-Skid jumpsuit/coveralls; Extra Protection jumpsuit/coveralls; Basic jumps uit/coveralls; Basic Lab coats; Universal precautions Lab coat. At the request of the Central Region (6, 7 & 8) MTFs, vendors will provide on-site support and in-servicing during implementation, educational resources and tools for clinical use of th e product, conversion information, prime vendor order numbers, MSDS information, and itemization of the brands, types and packaging information of the products supplied by the vendor. C. Instructions to Vendors. INTERESTED RESPONDENTS MUST PROVIDE DETAILED HARD COPY RESPONSES TO THE TECHNICAL CRITERIA REQUIREMENTS STATED WITHIN THIS NOTICE BY 3PM CST ON 18 March 2008. Vendors that fail to meet th is submittal deadline will be disqualified from participating. This process will include vendor requirements to provide hard copy responses to technical criteria, no charge samples for clinical evaluation, and submission of electronic best price q uotes. Due to the potential for mail to be lost, vendors must confirm with the Regional POC stated below that their submission, quotes, and literature or other requested information has actually arrived at the Tri-Service Regional Business Office (TRBO). Each submitting vendor will confirm receipt, allowing adequate time for resubmission before the due date/time, should a problem occur with the first submission. Responses should be sent via your preferred delivery carrier with a requested return re ceipt and/or tracking number to Mr. Jim Quinn, Tri-Service Regional Business Office, 7800 IH-10 West, Suite 220, San Antonio TX 78230. (ELECTRONIC SUBMISSIONS TO INITIAL ANNOUNCEMENT ARE NO LONGER ACCEPTED) All e-mail communication between vendors and the region should be digitally signed. Contact Mr. Jim Quinn at (210) 292-3295 prior to the closing date of this announcement with any further questions. D. Evaluation Criteria. The Tri-Service Product Review Board (TPRB) is the governing body of the standardization process. This board includes clinicians and logisticians from the Military Treatment Facilities within the Central Region (6, 7 & 8). They are the deciding officials for this initiative. Phase I  Technical/Company E valuation Process. Interested respondents are to respond to this FBO announcement by mailing their intent to participate with hard copies of the following information: company name, point of contact, address, phone number, fax, email address, announcement number, DAPA number and complete answers to the technical criteria to the above POC by the required response date. Vendors are required to meet/provide responses to the technical/company criteria stated below. All technical/company criteria are weighted equally. The responses will be reviewed under the purview of the CPT to determine the acceptability of each vendor. After the review of the technical/company criteria, those vendors who meet these criteria will be qualified/invited to participate in the clinical/performance evaluation. All e-mail communication between vendors and the region should be digitally signed. Also, all communications of significant milestones, such as invitations to participate, notices of disqualification, etc. must be digital ly signed. Acceptability for purposes of evaluation of technical/company criteria: Generally, responses to all questions in this section demonstrate: (1) the business concern submitting the quote is a distributor or manufacturer of a complete line of the subject medical/surgical consumables; (2) based on the vendors responses, the evaluators have reasonable confidence that the line or products and/or services submitted meet the medical standards of care of the community, applicable to such products or services; (3) the vendor has or is obtaining a DAPA for the items (vendors that fail to have a DAPA will be disqualified); (4) the vendor has, or is obtaining, an agreement covering the items with Cardinal Health, the Prime Vendor for the region (vendo rs whose products are not available through the regional PV will be disqualified); (5) the vendor intends to provide discounts off DAPA for all products included in this standardization initiative (vendors that fail to provide a discount from DAPA will be disqualified); and (6) the vendors information provided is factually correct. Any misrepresentation of information will disqualify the vendor from further con sideration. The following Technical/Company Evaluation Criteria have been established for this standardization initiative: 1. Vendor must manufacture and/or distribute a complete product line of Disposable Protective Apparel-Laboratory Appar el. A complete line of product is defined as the MTFs requirements for usage items in the product line. Usage items are defined in the Medical/Surgical Prime Vendor contract statement of work as DAPA items ordered at least once per month, and at least one unit per order. At a minimum, this includes: Professional Jacket with knit cuffs  Universal Size; Non-Skid jumpsuit/coveralls; Extra Protection jumpsuit/coveralls; Basic jumpsuit/coveralls; Basic Lab coats; Universal precautions Lab coat. Provide certification of all brands of this product line that you manufacturer or distribute with the initial submittal. 2. Vendors must have a DAPA or be in the process of applying for a DAPA number for the Disposable Protective Apparel-Laboratory Apparel pr oduct line. Provide the DAPA number or proof of the application process with the initial submittal. (Note that vendors that fail to have a DAPA or show a lack of progress in obtaining a DAPA will be disqualified.) 3. Vendors must have a separate agree ment with the regional prime vendor, Cardinal Health for distribution in this Region and provide certification of this with the initial submittal. (Note that vendors whose products are not available through the regional PV will be disqualified.) 4. Ven dors must provide discounts off DAPA for all products included in this standardization initiative. Where lower Federal Supply Schedule prices are available, DAPA holders are required by previous agreement to provide the FSS price as their DAPA price. The refore, FSS prices do not represent discounts off the DAPA. (Note that vendors that fail to provide a discount from DAPA will be disqualified.) 5. Vendors must provide electronic and hard copy pricing quotes and a competitive product cross-reference in the prescribed (by the TRBO) electronic Microsoft Excel format upon request. 6. Vendor must provide educational tools and materials for Disposable Protective Apparel-Laboratory Apparel as well as no cost samples for the evaluation. Describe your avail able company educational tools and material resources with the initial submittal. 7. Vendor must provide customer service (telephonic, onsite, website or email) for regional facilities. Identify company resources and capabilities for such support w ith the initial submittal. 8. Vendors must have a local vendor representative available in the region. Provide contact information, i.e. name, address, phone number, and e-mail address with the initial submittal. 9. Vendors must provide any history of back orders and/or FDA or company recalls that occurred during the most recent 24-month period for the Disposable Protective Apparel-Laboratory Apparel including dates, duration, cause, and resolution with their initial submittals. Vendors should pr ovide a context to include any mitigating factors for these situations, and any relief of resolution which may have been provided since there will be no further opportunity to explain these scenarios and their effects. 10. Vendors must provide a standar d industry warranty, at a minimum, that includes a return goods policy. Provide a copy of their policy with their initial submittals. The vendor warrants and implies that the items delivered hereunder are merchantable and fit for use for the particular p urpose described in this contract. 11. Vendor provided documentation that demonstrates the offered products meet ASTM 1670/1671 standards for Impervious gowns and NFPA Class I Standards for all products 12. Products must be available in a variety of sizes from Universal to adult (XS to XL) - provide list of sizes 13. Clothing must have reinforced seams  provide documentation. 14. Lab Coat/Warm-up ja ckets have long sleeves with elastic or knit cuffs and a button or snap front closure  provide documentation Phase II  Clinical/Performance Evaluation Process. The multi-disciplinary Clinical Product Team facilitated by the TRBO will request samp les (at no charge to the government) from the product line to be clinically evaluated at select Military Treatment Facilities. Vendors are required to ship their no cost samples directly to the designated MTFs and will be allowed 21 calendar days from the date of notification to complete the delivery. Samples must be shipped to arrive at the MTF by COB, 3PM CST, on the (21st ) calendar day after the notice to ship. Vendors failing to deliver by the deadline will be disqualified from further consideration in the standardization process. CPT teams will evaluate the product against the clinical/performance criteria in a clinical setting. All clinical/performance criteria are weighted equally. The clinical evaluation period is estimated to last app roximately eight weeks. The CPT will evaluate the clinical/performance criteria using a Likert-like one to five rating scale where as: One (Does not meet minimum needs - worst score), Two (Meet minimum needs but is not clinically recommended), Three (Meet minimum needs), Four (Exceed minimum needs), Five (Provides superior clinical advantages - best score). The CPT has established a target threshold of 3.0 for the clinical acceptability of products for standardization. The CPT will analyze this acceptabi lity as being at or near 3.0 depending on the break in the average scores and how closely scores are clustered near the Acceptability Target Threshold of 3.0. Subject to this review, products below this threshold will be clinically unacceptable and be dis qualified from further consideration for standardization. In the pre-source selection procedures above, the CPT will determine/approve that both product literature and sample sets are required for the evaluation. The CPT intends that clinical ev aluations be conducted in a clinical setting; however, the Government reserves the right to conduct evaluations in either a non-clinical or clinical setting or both. Clinical evaluations will be tabulated by the TRBO and results will be forwarded to the C PT for review. Clinical/Performance evaluation is more important than the price. Based on the clinical evaluation results, the CPT will provide a vendor selection recommendation to the TPRB. Clinical/Performance Criteria: During the pre-source s election procedures, the CPT will evaluate products based on the equally weighted clinical/performance criteria outlined below: Clinical Acceptability Target Threshold: 3.0 1. Lab Coats, jackets and/or jumpsuit/coveralls can be donned with out assistance (conserves personnel resources). 2. Lab Coats, jackets and/or jumpsuit/coveralls neck, waist, and sleeve closures stay secured (to provide barrier protection) 3. The quality of construction and product strength provides barrier protect ion and prevents staff exposure (critical areas reinforced, fasteners, ties, fabric, etc.). 4. The components are free from holes and defects (to provide barrier protection and prevent patient exposure). Phase III  Pricing Analysis Process. 1. The following elements will be considered in the pricing analysis: (1) Operational Impact of RIA prices on the Region (Post-Standardization Costs), (2) Potential Cost Avoidance, (3) Impact of Unmatched Lines, and (4) Impact on SKUs by each vendor. 2. Vendors that meet the 3.0 clinical acceptability target threshold will be qualified to submit best value pricing for analysis to the TRBO. Those vendors with results less than 3.0 will be disqualified from further consideration depending on the b reak in the average scores and how closely scores are clustered near the Acceptability Target Threshold as determined by the CPT. Vendors that have been disqua lified will be notified in writing at the conclusion of the evaluation process. 3. Vendors will be given 14 calendar days from the date of request to submit their best pricing quotes, in a prescribed format, based upon the total requirements of the Ce ntral Region (6, 7 & 8). The Region intends to evaluate quotes and select a vendor or vendor(s), without discussions. Vendor quotes should contain the vendor's best product matches for the products or product lines requested in this announcement. Vendor quotes should contain the vendor's best responses to all technical and/or company questions listed in this announcement. Vendor quotes should contain the vendor's best tiered-pricing discounts off of the vendor's DAPA pricing (based on committed volume o f 80% of the total requirements of the MTFs in the Region). Additionally, the Region reserves the right to conduct discussions and request revised quotes, if it is determined to be necessary. If a down-selection is made during the evaluation process, the Region may limit the number of quotes to the greatest number that will permit an efficient competition among vendors. 4. Those vendors that fail to respond as required will be disqualified from further consideration. 5. Vendors will forward pricing to the TRBO, and the TRBO will prepare a pricing analysis. Pricing will be based on a committed volume for a two-year period with possible one-year option periods not to exceed a total of 5 years. 6. The Technical/Company and Clinical/Performance evalua tion factors are considered significantly more important than cost or price. As the evaluation results become more equal, price will become more important. 7. The Central Region (6, 7 & 8) TPRB reviews the data for a best value decision. 8. The DS L will ensure that the prices, with discounts off the Distribution and Pricing Agreement (DAPA) will be a good value, in conjunction with the volume purchasing commitment, and the technical merit of the submittal. 9. The Central Region (6, 7 & 8) TPRB v otes for the best value for a single or multiple vendor selection(s). The selection of a single vendor is anticipated. However, if no single vendor can meet the total requirement of the Region, the Government reserves the right to make two or more selecti ons for RIAs. In this event, selection would be based on a combination of MTF preference and product availability.
 

Place of Performance

Address: Great Plains Regional Contracting Ofc ATTN: MCAA GP L31 9V, 3851 Roger Brooke Drive Fort Sam Houston TX

Zip Code: 78234-6200

Country: US
 

Record

SN01517216-W 20080228/080226224334 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |